Silverback Therapeutics Competitors and Similar CompaniesClear all

Silverback Therapeutics's competitors and similar companies include NovoCure.

	Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Founding Date	Founding Date 2016	Founding Date 2000
Type	Type Public	Type Public
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations Seattle, US HQ	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 9067% increase	Employees 1,488
Valuation ($)	Valuation ($) 550.4 m	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) $1.3m (FY, 2022)	Revenue (est.) $655.4m (FY, 2025)
Net income	Net income ($34.7m) (FY, 2022)	Net income ($136.2m) (FY, 2025)

For sources of this data, please see the company profile

Saint Helier, JE

Employees

1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

Financial